Backgrounds/Aims: Although recent advances in surgical techniques and alternative treatment, the long-term survival ＞5 years after liver resection for hepatocellular carcinoma (HCC) is still unsatisfactory due to the high recurrence rate compared with other solid organ cancers. This study was conducted to analyze long-term survival after HCC resection and to develop an optimal strategy to achieve long-term survival. Methods: A retrospective review was performed for HCC patients who underwent liver resection between 1996 and 2006. The survival rates and prognostic factors were assessed. The clinical and pathological factors of patients who survived more than 5 years were compared with those of patients whose survival was less than 5 years. The clinicopathological features characterizing long-term survivors were also reviewed. Results: The overall and disease-free 5-year survival rates of 87 cases were 38.5% and 29.4%, respectively. Twenty-seven of 87 patients survived longer than 5 years after liver resection. The univariate analysis revealed that hepatitis C, the serum aspartate sminotransferase (AST) level, liver cirrhosis, Edmondson-Steiner grade, AJCC stage, and vascular invasion were significant factors for overall survival, and serum AST level, liver cirrhosis, Edmondson-Steiner grade, AJCC stage, and vascular invasion were the affecting factors for disease-free survival. In multivariate analysis, serum AST level, hepatitis C and vascular invasion were related with the overall survival, liver cirrhosis and vascular invasion which were associated with disease-free survival. 
INTRODUCTION
As the initial clinical symptom of hepatocellular carcinoma (HCC) is not apparent, only a periodic examination makes it possible to be detected in the early stage. When it is detected with symptoms, intensive and extensive treatments are not feasible because of the regression of liver function accompanied by chronic liver disease or liver cirrhosis, 1,2 and even resection is possible, the 5-year survival rate is low owing to recurrence as compared with other solid cancers. 3, 4 Since the long-term survival rate is the most important index when estimating a treatment strategy for malignant cancer, many studies focused on treatment methods to increase the survival rate after treatments are in progress multilaterally. A single operation, such as a liver transplantation or liver resection which can eliminate all tumor cells leading to a non-tumorous state, and an operation with non-operative adjuvant therapy such as percutaneous ethanol injection therapy, radiofrequency ablation, and transcatheter arterial chemoembolization have been attempted.
But a high recurrence rate resulted in a low long-term survival rate. 5 Such a high rate of recurrence was related to mortality, so that there was a trial to increase the long-term survival rate by analyzing the factors associated with recurrence, but it has not yet been established. 6, 7 We had followed up the patients who had undergone liver resection, and evaluated the survival rate and prognostic factors. We tried to figure out the condition to derive the long-term survival rate by analyzing clinical and pathologic characteristics of two groups, the group surviving more than 5 years and the other group with short-term survival. 
Survival results and prognostic factors
The overall survival rate for all patients was 78.0% in the first year, 53.4% at 3 years, and 38.5% at 5 years, (Table 3) .
A total of 56 patients (64.4%) experienced tumor recurrence during the follow-up period, particularly in the liver (36 of 56) ( Table 4) . Among 56 patients with recurrence, 27 patients (48.2%) were treated mainly with transarterial chemoembolization, 10 patients did not receive any treatment (17.9%) ( Table 5) .
Comparison of the long-term survival group (L-group) and the short-term survival group (S-group)
The S-group showed more vascular invasion than the L-group (p=0.014), and stage I of the TMN classification was overwhelmingly dominant as compared to stage 2 and 3 in L-group, while stage 2 was most dominant, which was similar distribution with stage 2 and 3 in S-group (p=0.037). According to Edmondson-Steiner grade, grade 1 and 2 were more than grade 3 and 4 in both of the two groups, which was much more remarkable in the L-group (p=0.011) ( Table 6 ). Fourteen recurrences were found in the L-group and 42 in S-group. Intrahepatic tumor recurrence was found in 12 patients and two patients is closely related to long-term survival. 4, 6, 7 Examining previous studies on the factors that influence the recurrent rate showed that there were some agreed upon factors which had shown a significant effect, but some factors were controversial. Hepatitis B and C Infection is known to be directly related to hepatocellular carcinoma, 4,9,10 but no significant relationship could be found in those studies due to the small number of samples similar to this study. 6 The size and number of tumors, vascular invasions, existence of satellite nodules, range of resections and ruptures of membrane of tumors, suggested in previous studies 7, [11] [12] [13] may influence recurrence. Most studies 7, 12, 13 mentioned that vascular invasion was a direct tumor forming factor through circulation. This had significant results for our study as well (p=0.001). For the size of tumor, many studies [12] [13] [14] admitted that the significance that a tumor larger than 5 cm had a higher recurrence rate, 6,12,13 but there was no statistical significance in our study (p=0.258). Lee and his collegues 15 concluded that the tumor size did not have any statistical significance in their multivariate analysis, which was analyzed at every 1 cm of size from 2 cm to 7 cm. Although this study did not investigate the existence and rupture of the membrane, Laurent et al. 16 found in their multivariate study that the recurrence rate was high when the membrane was ruptured. Another study 17 reported the poor survival rate with the rupture of the tumor itself, on the other hand Han et al. 18 found no difference in the survival rate according to the existence of a membrane, but they reported a difference in survival rate whether or not the tumor cell invaded the membrane.
Many studies reported a poor result with multiple tumor masses, but this study found no statistical significance. 7, 11, 18 Bleeding remains a major problem with liver resections.
Blood transfusion of any amount, as shown some studies, is related to shortening the overall cumulative and disease-free survival periods. 17, [19] [20] [21] But it is considered the reflection of the severity of progressive cirrhosis which causes massive blood loss, not by blood transfusion. To reduce bleeding during mobilization of the tumor, adequate and wide exposure by a generous incision and adequate illumination of the operative field are essential. In our study, transfusion related to the operation had no significance.
Many institutions 11, 13, 16 noted that a free margin of parenchyma has been regarded as a prognostic factor in terms of long-term survival and tumor recurrence, but this had no significance in our study. Shah et al. 13 mentioned that cirrhosis was associated with recurrence, our study also found cirrhosis related to high recurrence rates.
HCC recurred in the intrahepatic region as reported by many institutions. [22] [23] [24] In our study, there were 64.4%
postoperative recurrences, and among these, intrahepatic recurrence was 64.3%. If a recurred hepatocellular carcinoma is detected early in the intrahepatic region, it is not only possible to resect all of lesion, but the non-operative modality, such as transarterial embolizaion or radiofrequency ablation, also this can be performed when an operation is not possible because of a poor general condition.
To improve the survival rate, it is important to prevent and detect recurrence, yet further study on prevention is needed. Closer follow-up in the out-patient department with more frequent radiologic study (USG or CT) and serologic tumor marker study (AFP) and perhaps with magnetic resonance imaging studies of the liver to detect an early recurrence should be considered. Additionally, patients with an extremely high surgical risk can be treated with other treatment modalities such as transarterial embolizaion or radiofrequency ablation.
